| 注册
首页|期刊导航|化工学报|改性聚乳酸-聚乙二醇--多西紫杉醇给药系统的制备

改性聚乳酸-聚乙二醇--多西紫杉醇给药系统的制备

李瑞端 张建军 陈建峰 滕巍 李彩霞 王洁欣

化工学报Issue(6):2357-2362,6.
化工学报Issue(6):2357-2362,6.DOI:10.3969/j.issn.0438-1157.2014.06.055

改性聚乳酸-聚乙二醇--多西紫杉醇给药系统的制备

Modified polylactic acid loading docetaxel for anticancer drug delivery

李瑞端 1张建军 1陈建峰 1滕巍 1李彩霞 1王洁欣1

作者信息

  • 1. 北京化工大学有机无机复合材料国家重点实验室,北京100029
  • 折叠

摘要

Abstract

Nanoparticles based on poly(2-amino-1, 3-propanediol carbonic ester-co-lactide) -g- PEG(P(LA-co-CA)-mPEG) were prepared by using the emulsion solvent diffusion method. The copolymer of P (LA-co-CA) was prepared by using ring-opening polymerization with diethylzinc (ZnEt2) as initiator, and then benzyl oxygen group was taken off to obtain P (LA-co-CA). With the anticancer drug, docetaxel (DTX), as a model drug, the morphology of nanoparticles was characterized with scanning electron microscopy (SEM) and the size and size distribution were determined by dynamic light scattering (DLS). SEM images and DLS results revealed that the particles were spherical in shape and about 100 nm in size, which was suitable for intravenous injection and close to the typically required size under physiological conditions. Thus, nanoparticles of P (LA-co-CA)-mPEG could be used as biodegradable, biocompatible, and cell-specific targetable nano-structured carriers for intracellular delivery of hydrophobic anticancer drugs.

关键词

结晶/合成/纳米粒子/聚乳酸/多西紫杉醇/共聚物

Key words

crystallization/synthesis/nanoparticles/polylactide/docetaxel/copolymer

分类

化学化工

引用本文复制引用

李瑞端,张建军,陈建峰,滕巍,李彩霞,王洁欣..改性聚乳酸-聚乙二醇--多西紫杉醇给药系统的制备[J].化工学报,2014,(6):2357-2362,6.

基金项目

国家自然科学基金项目(51303009),国家高技术研究发展计划项目(2013AA032201)。@@@@supported by the National Natural Science Foundation of China (51303009)and the National High Technology Research Development Program of China (2013AA032201) (51303009)

化工学报

OA北大核心CSCDCSTPCD

0438-1157

访问量0
|
下载量0
段落导航相关论文